Author: LI, Xunliang; LI, Pengchong; CAO, Liyan; BAI, Yunyun; CHEN, Huijie; LIU, He; REN, Xiaofeng; LI, Guangxing
Title: Porcine IL-12 plasmid as an adjuvant improves the cellular and humoral immune responses of DNA vaccine targeting transmissible gastroenteritis virus spike gene in a mouse model Document date: 2019_9_2
ID: rme6b022_5
Snippet: Eukaryotic expression plasmids are able to induce a robust immune response via endocytosis and antigen-presenting cells [14] . DNA vaccines offer advantages, as they contain no actual infectious agents, can be easily transported, and may induce effective cellular and humoral immune responses. Therefore, nucleic acid vaccines could serve as effective alternatives for diseases control. Several reports have suggested the addition of a cytokine as an.....
Document: Eukaryotic expression plasmids are able to induce a robust immune response via endocytosis and antigen-presenting cells [14] . DNA vaccines offer advantages, as they contain no actual infectious agents, can be easily transported, and may induce effective cellular and humoral immune responses. Therefore, nucleic acid vaccines could serve as effective alternatives for diseases control. Several reports have suggested the addition of a cytokine as an adjuvant to increase vaccine efficacy. Interleukin (IL)-12 shows a central function in initiating and regulating cellular immune responses, and many studies have analyzed the use of IL-12 as a potential vaccine adjuvant [2, 17] .
Search related documents:
Co phrase search for related documents- dna vaccine and infectious agent: 1
- dna vaccine and nucleic acid: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- dna vaccine and nucleic acid vaccine: 1, 2, 3
- dna vaccine and vaccine adjuvant: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32
- dna vaccine and vaccine efficacy: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51
- immune response and infectious agent: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49
- immune response and nucleic acid: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74
- immune response and nucleic acid vaccine: 1, 2, 3, 4
- immune response and vaccine adjuvant: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- immune response and vaccine efficacy: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- immune response and vaccine efficacy increase: 1, 2, 3, 4, 5, 6
- immune response and vaccine efficacy increase adjuvant: 1
- infectious agent and nucleic acid: 1, 2, 3, 4, 5, 6, 7, 8
- infectious agent and vaccine adjuvant: 1, 2, 3
- infectious agent and vaccine efficacy: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- nucleic acid and vaccine adjuvant: 1, 2, 3, 4, 5, 6, 7
- nucleic acid and vaccine efficacy: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- nucleic acid vaccine and vaccine adjuvant: 1, 2
- nucleic acid vaccine and vaccine efficacy: 1
Co phrase search for related documents, hyperlinks ordered by date